In a previous familial adenomatous polyposis study [14], comparable treatment effects of a cyclooxygenase-2 inhibitor were observed on the fatty acid composition in serum phospholipids and duodenal lesions, presumably and most importantly the nonbeneficial effects involving essential fatty acids. The gene discussed is PTGS2; the disease is Familial adenomatous polyposis.